Download PDF
Drug Res (Stuttg) 2019; 69(08): 428-433
DOI: 10.1055/a-0817-5464
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Spinal Serotonin and 5HT6 Receptor Levels During Development of Neuropathy and Influence of Blockade of these Receptors on Thermal Hyperalgesia in Diabetic Mice[*]

Cagda Celik Sari
1   Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, Turkey
,
Ozgur Gunduz
1   Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, Turkey
,
Ahmet Ulugol
1   Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, Turkey
› Author Affiliations
Further Information

Publication History

received 15 November 2018

accepted 04 December 2018

Publication Date:
04 January 2019 (online)

Also available at
   Permissions and Reprints

Abstract

Little is known about the role of 5-HT6 receptors in the pathophysiology of neuropathic pain. The aim of this study is firstly, to investigate the influence of spinal and systemic 5-HT6 receptors on thermal hyperalgesia, one of the most significant symptoms of neuropathy occurring in diabetes; and secondly to determine spinal lumbar serotonin and 5-HT6 receptor levels during development of diabetic neuropathy in mice. Diabetes was produced in Balb/c mice with a single injection of streptozocin (150 mg/kg, i.p.). Using the hot plate test, the 5-HT6 antagonist SB-258585 was given systemically (3, 10, 30 mg/kg) and intrathecally (0.01, 0.1, 1 nmol/mouse) to determine its effect on thermal hyperalgesia. Furthermore, on days 7 and 15 of diabetes, development of thermal hyperalgesia was evaluated in relation to changes in spinal serotonin and 5-HT6 receptor levels by using LC/MS/MS and Western blot analyses, respectively. Two-way analysis of variance and unpaired t-tests were used to evaluate data from hot-plate tests and 5-HT levels/ 5-HT6 receptor expression, respectively. Thermal hyperalgesia was observed in neuropathic mice, starting from day 5 after streptozocin administration. On day 15, systemic, but not intrathecal, SB-258585 attenuated thermal hyperalgesia in neuropathic mice. Spinal serotonin levels did not change during development of hyperalgesia after induction of diabetes, whereas spinal 5-HT6 receptor levels were significantly reduced on days 7 and 15. Our findings show that systemic, but not spinal, blockade of 5-HT6 receptors may exert antihyperalgesic effects in neuropathic mice and suggest that systemic 5-HT6 receptors contribute to the pathophysiology of diabetic neuropathy.

Key words

diabetic neuropathy - neuropathic pain - serotonin - 5-HT6 receptors - thermal hyperalgesia

* Presented at the “17th World Congress on Pain”, Boston, USA, 12–16 September 2018.


 

  • References

  • 1 Colloca L, Ludman T, Bouhassira D. et al. Neuropathic pain. Nat Rev Dis Primers. 2017; 3: 17002
    PubMedGoogle Scholar
  • 2 Colvin LA, Dougherty PM. Peripheral neuropathic pain: signs, symptoms, mechanisms, and causes: Are they linked?. Brit J Anaesth 2015; 114: 361-363
    CrossrefPubMedGoogle Scholar
  • 3 Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: Clinical manifestations and mechanisms. Lancet Neurol 2014; 13: 924-935
    CrossrefPubMedGoogle Scholar
  • 4 Ulugol A, Aslantas A, Karadag HC. et al. The effect of combined systemic administration of morphine and L-name, a nitric oxide synthase inhibitor, on behavioral signs of neuropathic pain in rats. Neurosci Res Commun 2002; 30: 143-153
    CrossrefPubMedGoogle Scholar
  • 5 Finnerup NB, Attal N, Haroutounian S. et al. Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. Lancet Neurol 2015; 14: 162-173
    CrossrefPubMedGoogle Scholar
  • 6 Dworkin RH, O’Connor AB, Kent J. et al. Interventional management of neuropathic pain: NeuPSIG recommendations. Pain 2013; 154: 2249-2261
    CrossrefPubMedGoogle Scholar
  • 7 Gunduz O, Oltulu C, Guven R. et al. Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats. Neurol Sci 2011; 32: 1135-1142
    CrossrefPubMedGoogle Scholar
  • 8 Bardin L. The complex role of serotonin and 5-HT receptors in chronic pain. Behavioural Pharmacology 2011; 22: 390-404
    CrossrefPubMedGoogle Scholar
  • 9 Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66: 355-474
    CrossrefPubMedGoogle Scholar
  • 10 Viguier F, Michot B, Hamon M. et al. Multiple roles of serotonin in pain control mechanisms -Implications of 5-HT7 and other 5-HT receptor types. European Journal of Pharmacology 2013; 716: 8-16
    CrossrefPubMedGoogle Scholar
  • 11 Cervantes-Duran C, Rocha-Gonzalez HI, Granados-Soto V. Peripheral and spinal 5-HT receptors participate in the pronociceptive and antinociceptive effects of fluoxetine in rats. Neuroscience 2013; 252: 396-409
    CrossrefPubMedGoogle Scholar
  • 12 Godinez-Chaparro B, Barragan-Iglesias P, Castaneda-Corral G. et al. Role of peripheral 5-HT4, 5-HT6, and 5-HT7 receptors in development and maintenance of secondary mechanical allodynia and hyperalgesia. Pain 2011; 152: 687-697
    CrossrefPubMedGoogle Scholar
  • 13 Sommer C. Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol 2004; 30: 117-125
    CrossrefPubMedGoogle Scholar
  • 14 Godinez-Chaparro B, Lopez-Santillan FJ, Orduna P. et al. Secondary mechanical allodynia and hyperalgesia depend on descending facilitation mediated by spinal 5-HT4, 5-HT6 and 5-HT7 receptors. Neuroscience 2012; 222: 379-391
    CrossrefPubMedGoogle Scholar
  • 15 Oyama T, Ueda M, Kuraishi Y. et al. Dual effect of serotonin on formalin-induced nociception in the rat spinal cord. Neuroscience Research 1996; 25: 129-135
    CrossrefPubMedGoogle Scholar
  • 16 Aksu AG, Gunduz O, Ulugol A. Contribution of spinal 5-HT5A receptors to the antinociceptive effects of systemically administered cannabinoid agonist WIN 55,212-2 and morphine. Can J Physiol Pharmacol 2018; 96: 618-623
    CrossrefPubMedGoogle Scholar
  • 17 Gencer A, Gunduz O, Ulugol A. Involvement of descending serotonergic and noradrenergic systems and their spinal receptor subtypes in the antinociceptive effect of dipyrone. Drug Res 2015; 65: 645-649
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Ruat M, Traiffort E, Arrang JM. et al. A novel rat serotonin (5-HT6) receptor - molecular-cloning, localization and stimulation of cAMP accumulation. Biochem Bioph Res Co 1993; 193: 268-276
    CrossrefPubMedGoogle Scholar
  • 19 Gerard C, ElMestikawy S, Lebrand C. et al. Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse 1996; 23: 164-173
    CrossrefPubMedGoogle Scholar
  • 20 Castaneda-Corral G, Rocha-Gonzalez HI, Araiza-Saldana CI. et al. Role of peripheral and spinal 5-HT(6) receptors according to the rat formalin test. Neuroscience 2009; 162: 444-452
    CrossrefPubMedGoogle Scholar
  • 21 Finn DP, Forte KCF, Beckett SRG. et al. The effects of pharmacological blockade of the 5-HT6 receptor on formalin-evoked nociceptive behaviour, locomotor activity and hypothalamo-pituitary-adrenal axis activity in rats. European Journal of Pharmacology 2007; 569: 59-63
    CrossrefPubMedGoogle Scholar
  • 22 Devegowda VN, Hong JR, Cho S. et al. Synthesis and the 5-HT6 receptor antagonistic effect of 3-arylsulfonylamino-5,6-dihydro-6-substituted pyrazolo[3,4]pyridinones for neuropathic pain treatment. Bioorg Med Chem Lett 2013; 23: 4696-4700
    CrossrefPubMedGoogle Scholar
  • 23 Hong JR, Choo H, Nam G. Neuropathic pain-alleviating effects of pyrazole-conjugated arylsulfonamides as 5-HT6 receptor antagonists. Bioorg Med Chem Lett 2017; 27: 4146-4149
    CrossrefPubMedGoogle Scholar
  • 24 Pineda-Farias JB, Barragan-Iglesias P, Valdivieso-Sanchez A. et al. Spinal 5-HT4 and 5-HT6 receptors contribute to the maintenance of neuropathic pain in rats. Pharmacol Rep 2017; 69: 916-923
    CrossrefPubMedGoogle Scholar
  • 25 Jayarajan P, Nirogi R, Shinde A. et al. 5-HT6 receptor antagonist attenuates the memory deficits associated with neuropathic pain and improves the efficacy of gabapentinoids. Pharmacol Rep 2015; 67: 934-942
    CrossrefPubMedGoogle Scholar
  • 26 Gunduz O, Karadag CH, Ulugol A. Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice. J Neural Transm 2010; 117: 1027-1032
    CrossrefPubMedGoogle Scholar
  • 27 Gunduz O, Topuz RD, Karadag CH. et al. Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice. European Journal of Pain 2016; 20: 465-471
    CrossrefPubMedGoogle Scholar
  • 28 Ulugol A, Oltulu C, Gunduz O. et al. 5-HT7 receptor activation attenuates thermal hyperalgesia in streptozocin-induced diabetic mice. Pharmacology Biochemistry and Behavior 2012; 102: 344-348
    CrossrefPubMedGoogle Scholar
  • 29 Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980; 67: 313-316
    CrossrefPubMedGoogle Scholar
  • 30 Ulugol A, Topuz RD, Gunduz O. et al. Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance. Fundam Clin Pharmacol 2016; 30: 537-548
    CrossrefPubMedGoogle Scholar
  • 31 Kizilay G, Cakmak H, Yen CF. et al. Expression and regulation of c-Jun N-terminal kinase (JNK) in endometrial cells in vivo and in vitro. Histochem Cell Biol 2008; 130: 761-771
    CrossrefPubMedGoogle Scholar
  • 32 Calcutt NA, Chaplan SR. Spinal pharmacology of tactile allodynia in diabetic rats. Br J Pharmacol 1997; 122: 1478-1482
    CrossrefPubMedGoogle Scholar
  • 33 Field MJ, McCleary S, Hughes J. et al. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 1999; 80: 391-398
    CrossrefPubMedGoogle Scholar
  • 34 Suzuki R, Rygh LJ, Dickenson AH. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends in Pharmacological Sciences 2004; 25: 613-617
    CrossrefPubMedGoogle Scholar
  • 35 Morgado C, Silva L, Pereira-Terra P. et al. Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy: The preventive action of IGF1. Neurobiology of Disease 2011; 43: 275-284
    CrossrefPubMedGoogle Scholar
  • 36 Leong ML, Gu M, Speltz-Paiz R. et al. Neuronal loss in the rostral ventromedial medulla in a rat model of neuropathic pain. Journal of Neuroscience 2011; 31: 17028-17039
    CrossrefPubMedGoogle Scholar